Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm
Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic neurochemical agents. Recent attention has been given to the potential anxiolytic properties of cannabidiol, because of its complex actions on th...
Saved in:
Published in: | Neuropsychopharmacology (New York, N.Y.) Vol. 37; no. 2; pp. 412 - 421 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Basingstoke
Nature Publishing Group
01-01-2012
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic neurochemical agents. Recent attention has been given to the potential anxiolytic properties of cannabidiol, because of its complex actions on the endocannabinoid system together with its effects on other neurotransmitter systems. The aim of this study was to investigate the effects of cannabidiol on innate fear-related behaviors evoked by a prey vs predator paradigm. Male Swiss mice were submitted to habituation in an arena containing a burrow and subsequently pre-treated with intraperitoneal administrations of vehicle or cannabidiol. A constrictor snake was placed inside the arena, and defensive and non-defensive behaviors were recorded. Cannabidiol caused a clear anti-aversive effect, decreasing explosive escape and defensive immobility behaviors outside and inside the burrow. These results show that cannabidiol modulates defensive behaviors evoked by the presence of threatening stimuli, even in a potentially safe environment following a fear response, suggesting a panicolytic effect. |
---|---|
AbstractList | Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic neurochemical agents. Recent attention has been given to the potential anxiolytic properties of cannabidiol, because of its complex actions on the endocannabinoid system together with its effects on other neurotransmitter systems. The aim of this study was to investigate the effects of cannabidiol on innate fear-related behaviors evoked by a prey vs predator paradigm. Male Swiss mice were submitted to habituation in an arena containing a burrow and subsequently pre-treated with intraperitoneal administrations of vehicle or cannabidiol. A constrictor snake was placed inside the arena, and defensive and non-defensive behaviors were recorded. Cannabidiol caused a clear anti-aversive effect, decreasing explosive escape and defensive immobility behaviors outside and inside the burrow. These results show that cannabidiol modulates defensive behaviors evoked by the presence of threatening stimuli, even in a potentially safe environment following a fear response, suggesting a panicolytic effect. Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic neurochemical agents. Recent attention has been given to the potential anxiolytic properties of cannabidiol, because of its complex actions on the endocannabinoid system together with its effects on other neurotransmitter systems. The aim of this study was to investigate the effects of cannabidiol on innate fear-related behaviors evoked by a prey vs predator paradigm. Male Swiss mice were submitted to habituation in an arena containing a burrow and subsequently pre-treated with intraperitoneal administrations of vehicle or cannabidiol. A constrictor snake was placed inside the arena, and defensive and non-defensive behaviors were recorded. Cannabidiol caused a clear anti-aversive effect, decreasing explosive escape and defensive immobility behaviors outside and inside the burrow. These results show that cannabidiol modulates defensive behaviors evoked by the presence of threatening stimuli, even in a potentially safe environment following a fear response, suggesting a panicolytic effect. |
Author | FRANCISCO, Audrey ANGELICA CASTIBLANCO-URBINA, Maria TWARDOWSCHY, Andre CYSNE COIMBRA, Norberto CRIPPA, Jose Alexandre S JOSE SALGADO-ROHNER, Carlos URIBE-MARINO, Andres WALDO ZUARDI, Antonio CECILIO HALLAK, Jaime Eduardo |
Author_xml | – sequence: 1 givenname: Andres surname: URIBE-MARINO fullname: URIBE-MARINO, Andres organization: Laborotório de Neuroanatomia and Neuropsicobiologia, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto do Universidade de São Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 2 givenname: Audrey surname: FRANCISCO fullname: FRANCISCO, Audrey organization: Laborotório de Neuroanatomia and Neuropsicobiologia, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto do Universidade de São Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 3 givenname: Maria surname: ANGELICA CASTIBLANCO-URBINA fullname: ANGELICA CASTIBLANCO-URBINA, Maria organization: Laborotório de Neuroanatomia and Neuropsicobiologia, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto do Universidade de São Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 4 givenname: Andre surname: TWARDOWSCHY fullname: TWARDOWSCHY, Andre organization: Laborotório de Neuroanatomia and Neuropsicobiologia, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto do Universidade de São Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 5 givenname: Carlos surname: JOSE SALGADO-ROHNER fullname: JOSE SALGADO-ROHNER, Carlos organization: Laborotório de Neuroanatomia and Neuropsicobiologia, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto do Universidade de São Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 6 givenname: Jose Alexandre S surname: CRIPPA fullname: CRIPPA, Jose Alexandre S organization: Departamento de Neurociências e Ciências do Comportamento, Setor de Psiquiotria, Faculdade de Medicina de Ribeirão Preto do Universidade de Sio Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 7 givenname: Jaime Eduardo surname: CECILIO HALLAK fullname: CECILIO HALLAK, Jaime Eduardo organization: Departamento de Neurociências e Ciências do Comportamento, Setor de Psiquiotria, Faculdade de Medicina de Ribeirão Preto do Universidade de Sio Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 8 givenname: Antonio surname: WALDO ZUARDI fullname: WALDO ZUARDI, Antonio organization: Departamento de Neurociências e Ciências do Comportamento, Setor de Psiquiotria, Faculdade de Medicina de Ribeirão Preto do Universidade de Sio Paulo (USP), Ribeirão Preto (SP), Brazil – sequence: 9 givenname: Norberto surname: CYSNE COIMBRA fullname: CYSNE COIMBRA, Norberto organization: Laborotório de Neuroanatomia and Neuropsicobiologia, Departamento de Farmacologia, Faculdade de Medicina de Ribeirão Preto do Universidade de São Paulo (USP), Ribeirão Preto (SP), Brazil |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25641789$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21918503$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks9v0zAUxyM0xLrBjTOykBA7kPJsp4lzmdRVHVQaohIgdoteHKf1mtrFdiL1T-S_mquV8ePAyXr2Rx-_Z3_PkhNjjUqSlxTGFLh4b3a7MQNKx1SIJ8mIFhmkOc9uT5IRiJKnlPPb0-TM-zsAOily8Sw5ZbSkYgJ8lPycmqDT6aCc14Mi87ZVMnhiWzJDY7DWjbYdsYYsYhUUuVbo0oVpeqkacqXWOGjrPJkPdhM36j1BQ-ZhbTu70hI78sk2qjvolmi0JNMQUG48uUIf8ahFsnRqTwZPwlqR77pryBeDm9jJTksXb_REKiPXTiOJtfe9JzNrWmdNwKCjYYkOG73aPk-etth59eK4niffrudfZx_Tm88fFrPpTSqzgoeUFVBPCqAKy7oBycqGtRllHAuhZJ6Voi1a0dZlntUlhaxmCCxHhDrDXFBo-Hly-eDd9fVWNbG74LCrdk5v0e0ri7r6-8TodbWyQ8VZxjiwKHh7FDj7o1c-VFvtpeo6NMr2viopLXleiAN58V-SAgiRQQEQ0df_oHe2dyY-RPQBL0XOigi9e4Cks9471T52TaE6hKmKYaoOYapimCL-6s9JH-Ff6YnAmyOAPn5269BI7X9zkzyjRczgPVaQ1qI |
CODEN | NEROEW |
CitedBy_id | crossref_primary_10_1002_jat_3831 crossref_primary_10_1177_0269881118822078 crossref_primary_10_1177_0269881118806301 crossref_primary_10_1177_02698811221115755 crossref_primary_10_1515_revneuro_2018_0023 crossref_primary_10_1007_s00213_023_06309_7 crossref_primary_10_1002_jat_3631 crossref_primary_10_1016_j_bbr_2020_112996 crossref_primary_10_1002_jnr_25300 crossref_primary_10_1016_j_cbi_2021_109743 crossref_primary_10_1016_j_neuropharm_2016_10_001 crossref_primary_10_1016_j_neuropharm_2023_109831 crossref_primary_10_1016_j_brainres_2019_146468 crossref_primary_10_1016_j_pnpbp_2012_10_024 crossref_primary_10_1002_syn_21814 crossref_primary_10_1016_S1516_4446_12_70057_0 crossref_primary_10_1016_j_reprotox_2018_06_013 crossref_primary_10_1111_bph_13724 crossref_primary_10_1007_s00213_022_06127_3 crossref_primary_10_1111_fcp_12373 crossref_primary_10_3389_fpubh_2021_626853 crossref_primary_10_1111_adb_12495 crossref_primary_10_1159_000521184 crossref_primary_10_2174_1389201022666210122125131 crossref_primary_10_1016_j_neubiorev_2012_09_001 crossref_primary_10_1007_s00213_022_06258_7 crossref_primary_10_21307_ane_2020_017 crossref_primary_10_1159_000502439 crossref_primary_10_1177_0269881118769061 crossref_primary_10_1186_s13229_022_00511_8 crossref_primary_10_1007_s00702_020_02217_8 crossref_primary_10_1016_j_ejphar_2012_07_038 crossref_primary_10_1016_j_neuropharm_2017_09_010 crossref_primary_10_1007_s13311_015_0387_1 crossref_primary_10_1016_j_brainresbull_2021_06_017 crossref_primary_10_1016_j_neuroscience_2017_04_032 crossref_primary_10_1089_can_2022_0130 crossref_primary_10_1007_s00213_019_05435_5 crossref_primary_10_1016_j_abb_2020_108574 crossref_primary_10_1016_j_neuroscience_2015_06_048 crossref_primary_10_1016_j_nlm_2013_03_004 crossref_primary_10_1177_0269881113493363 crossref_primary_10_1016_j_neuroscience_2017_11_031 crossref_primary_10_1016_j_neuropharm_2016_04_003 crossref_primary_10_1016_j_bbr_2016_11_026 crossref_primary_10_1007_s00424_022_02672_0 crossref_primary_10_1016_j_brainres_2020_146907 crossref_primary_10_1016_j_brainres_2014_11_062 crossref_primary_10_1098_rstb_2011_0389 crossref_primary_10_3390_molecules29020473 crossref_primary_10_3389_fphar_2020_618065 crossref_primary_10_1007_s13311_015_0373_7 crossref_primary_10_3390_ph14100965 crossref_primary_10_1016_j_physbeh_2018_07_021 crossref_primary_10_1016_j_bbr_2015_10_059 crossref_primary_10_1016_j_pnpbp_2024_111039 crossref_primary_10_1111_ejn_15548 crossref_primary_10_1186_s12915_022_01486_x crossref_primary_10_1177_0269881120967881 crossref_primary_10_1016_j_bbr_2017_07_016 crossref_primary_10_1016_j_bbr_2015_07_013 crossref_primary_10_1016_j_euroneuro_2017_09_002 crossref_primary_10_1016_j_ejphar_2015_03_051 crossref_primary_10_1177_02698811221128018 crossref_primary_10_1007_s00213_019_5170_2 crossref_primary_10_1016_j_neubiorev_2014_03_006 crossref_primary_10_1590_1516_4446_2015_1895 |
Cites_doi | 10.1177/026988119300700112 10.1016/j.pbb.2003.12.009 10.2174/156800705774933069 10.1007/s00213-008-1156-1 10.1016/j.bbr.2008.12.035 10.1007/BF02244012 10.1155/2009/625469 10.1080/15622970801908047 10.1016/j.expneurol.2005.08.022 10.1016/S0149-7634(99)00031-7 10.1016/j.jchemneu.2005.07.004 10.1038/sj.bjp.0707133 10.1016/j.neuroscience.2008.11.037 10.1111/j.1476-5381.2008.00046.x 10.1016/j.ejphar.2008.07.032 10.1007/s00213-008-1168-x 10.1176/appi.ajp.157.4.493 10.1016/S0361-9230(97)00141-X 10.1038/sj.npp.1300340 10.1007/s11064-005-6978-1 10.1016/j.bbr.2008.06.006 10.1016/0166-4328(86)90038-0 10.1073/pnas.0900939106 10.1161/01.STR.0000163083.59201.34 10.1016/j.jchemneu.2006.05.002 10.2741/3288 10.1097/FBP.0b013e32832c70b1 10.1196/annals.1369.052 10.1177/02698811000142S104 10.1038/sj.bjp.0704327 10.1016/j.brainres.2005.05.068 10.1016/S0028-3908(03)00235-1 10.1016/0278-5846(95)00305-3 10.1001/archgenpsychiatry.2008.519 10.1590/S1516-44462008000300015 10.1016/S0149-7634(01)00009-4 10.1590/S1516-44462010000500009 10.1016/S0149-7634(97)00054-7 10.1016/j.brainresbull.2004.06.007 10.1111/j.1755-5949.2008.00076.x 10.1016/S0028-3908(01)00155-1 10.1016/0166-4328(93)90159-N 10.1126/science.1144298 10.1016/j.beem.2008.09.003 10.1016/j.jneumeth.2007.05.023 10.1016/S0014-2999(03)01276-7 10.1016/j.tips.2009.07.006 10.1097/FBP.0b013e3283123c83 10.1016/j.jpsychires.2008.09.001 10.1016/j.brainres.2009.09.096 |
ContentType | Journal Article |
Copyright | 2015 INIST-CNRS Copyright Nature Publishing Group Jan 2012 Copyright © 2011 American College of Neuropsychopharmacology 2011 American College of Neuropsychopharmacology |
Copyright_xml | – notice: 2015 INIST-CNRS – notice: Copyright Nature Publishing Group Jan 2012 – notice: Copyright © 2011 American College of Neuropsychopharmacology 2011 American College of Neuropsychopharmacology |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM |
DOI | 10.1038/npp.2011.188 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Psychology MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Effects of cannabidiol on innate fear-induced behaviors |
EISSN | 1740-634X |
EndPage | 421 |
ExternalDocumentID | 2534739771 10_1038_npp_2011_188 21918503 25641789 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K -DZ -Q- 0R~ 1B1 29N 2WC 36B 39C 3V. 4.4 406 53G 5RE 5VS 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AADWK AAEDT AALRI AANZL AAPBV AAQFI AAQXK AATNV AAWBL AAXUO AAYFA AAYJO AAZLF ABGIJ ABIVO ABLJU ABMAC ABPTK ABUWG ACBMV ACBRV ACBYP ACGFO ACGFS ACIGE ACIUM ACKTT ACMJI ACPRK ACRQY ACTTH ACVWB ADBBV ADFRT ADHDB ADMDM ADMUD ADQMX ADYYL AEDAW AEFTE AEJRE AENEX AESKC AEVLU AEXYK AFKRA AFNRJ AFRAH AFSHS AGAYW AGEZK AGGBP AGHAI AHMBA AHSBF AILAN AJCLW AJDOV AJRNO ALFFA ALMA_UNASSIGNED_HOLDINGS AMRJV AMYLF AOIJS ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDB FDQFY FEDTE FERAY FGOYB FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HYE HZ~ IHE IQODW IWAJR JSO JZLTJ KQ8 M1P M2M M41 M7P MK0 NAO NQ- NQJWS NXXTH NYICJ O9- OK1 P2P P6G PQQKQ PROAC PSQYO PSYQQ Q2X R2- RIG RNS RNT RNTTT ROL RPM RPZ SEW SNX SNYQT SOHCF SRMVM SSZ SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI ZKB AACDK AASML AAYZH ABAKF ABZZP ACAOD ACZOJ AEFQL AEMSY AFBBN AGQEE AIGIU ALIPV CGR CUY CVF ECM EIF FIGPU HMCUK HVGLF LGEZI LOTEE NADUK NPM AAYXX CITATION 7TK 7XB 8FE 8FH 8FK K9. LK8 PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c473t-270b5701ea9bd0c29d2f4123a78ec6498f7f8fb964b9104b2a026aa0b4a6810d3 |
IEDL.DBID | RPM |
ISSN | 0893-133X |
IngestDate | Tue Sep 17 21:24:48 EDT 2024 Fri Oct 25 23:46:23 EDT 2024 Fri Oct 25 03:54:51 EDT 2024 Mon Nov 04 11:44:18 EST 2024 Thu Nov 21 22:15:39 EST 2024 Tue Oct 15 23:44:43 EDT 2024 Sun Oct 22 16:06:09 EDT 2023 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Panic Anxiety disorder Emotion emotionality Cannabinoid Ophidia cannabidiol Fear Vertebrata endocannabinoid-mediated system Endogenous innate fear Endocannabinoid prey vs predator paradigm panic-related responses Panic attack Reptilia Models Drug of abuse Behavior |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c473t-270b5701ea9bd0c29d2f4123a78ec6498f7f8fb964b9104b2a026aa0b4a6810d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://www.nature.com/articles/npp2011188.pdf |
PMID | 21918503 |
PQID | 910398627 |
PQPubID | 33935 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3242302 proquest_miscellaneous_911936782 proquest_miscellaneous_1008840700 proquest_journals_910398627 crossref_primary_10_1038_npp_2011_188 pubmed_primary_21918503 pascalfrancis_primary_25641789 |
PublicationCentury | 2000 |
PublicationDate | 2012-01-01 |
PublicationDateYYYYMMDD | 2012-01-01 |
PublicationDate_xml | – month: 01 year: 2012 text: 2012-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basingstoke |
PublicationPlace_xml | – name: Basingstoke – name: England – name: New York |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2012 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | 19273110 - Front Biosci (Landmark Ed). 2009;14:944-57 18446323 - Psychopharmacology (Berl). 2008 Aug;199(2):223-30 15845890 - Stroke. 2005 May;36(5):1077-82 18930474 - J Psychiatr Res. 2009 Mar;43(6):642-8 17717184 - Science. 2007 Aug 24;317(5841):1079-83 19162082 - Behav Brain Res. 2009 Jun 8;200(1):60-7 19729208 - Trends Pharmacol Sci. 2009 Oct;30(10):515-27 22290374 - J Psychopharmacol. 1993 Jan;7(1 Suppl):82-8 15996642 - Brain Res. 2005 Jul 27;1051(1-2):100-11 11606325 - Br J Pharmacol. 2001 Oct;134(4):845-52 10888028 - J Psychopharmacol. 2000;14(2 Suppl 1):S25-30 11378177 - Neurosci Biobehav Rev. 2001 May;25(3):205-18 19799880 - Brain Res. 2009 Dec 11;1305:118-31 10739407 - Am J Psychiatry. 2000 Apr;157(4):493-505 18691568 - Eur J Pharmacol. 2008 Sep 28;593(1-3):73-8 1969666 - Psychopharmacology (Berl). 1990;100(4):558-9 20512271 - Rev Bras Psiquiatr. 2010 May;32 Suppl 1:S56-66 19110037 - Neuroscience. 2009 Feb 18;158(4):1708-16 12600704 - Eur J Pharmacol. 2003 Feb 28;463(1-3):97-116 19285266 - Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):133-44 20218784 - World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):208-19 16140499 - J Chem Neuroanat. 2005 Dec;30(4):184-200 16258853 - Neurochem Res. 2005 Aug;30(8):1037-43 8861188 - Prog Neuropsychopharmacol Biol Psychiatry. 1996 Feb;20(2):185-205 8155280 - Behav Brain Res. 1993 Dec 31;59(1-2):131-9 11750915 - Neuropharmacology. 2002 Jan;42(1):48-59 9323445 - Brain Res Bull. 1997;44(3):297-305 15342106 - Brain Res Bull. 2004 Aug 30;64(2):181-8 19145562 - Rev Neurol. 2009 Jan 1-15;48(1):20-6 19273843 - Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4870-5 18446325 - Psychopharmacology (Berl). 2008 Jun;198(3):405-11 19133999 - Br J Pharmacol. 2009 Jan;156(1):181-8 17105950 - Ann N Y Acad Sci. 2006 Aug;1074:514-36 15006467 - Pharmacol Biochem Behav. 2004 Mar;77(3):557-66 19096514 - Neural Plast. 2009;2009:625469 3024664 - Behav Brain Res. 1986 Nov;22(2):173-80 14583744 - Neuropsychopharmacology. 2004 Feb;29(2):417-26 19228176 - CNS Neurosci Ther. 2009 Winter;15(1):19-23 19124693 - Arch Gen Psychiatry. 2009 Jan;66(1):95-105 17604117 - J Neurosci Methods. 2007 Sep 15;165(1):25-37 12941373 - Neuropharmacology. 2003 Oct;45(5):594-604 17245363 - Br J Pharmacol. 2007 Mar;150(5):613-23 7916235 - Braz J Med Biol Res. 1994 Apr;27(4):811-29 18833429 - Rev Bras Psiquiatr. 2008 Sep;30(3):271-80 16375681 - Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):633-42 10580312 - Neurosci Biobehav Rev. 1999 Nov;23(7):981-91 16303128 - Exp Neurol. 2006 Jan;197(1):93-112 9662722 - Neurosci Biobehav Rev. 1998 Sep;22(5):597-612 19421027 - Behav Pharmacol. 2009 May;20(3):265-72 18797248 - Behav Pharmacol. 2008 Oct;19(7):716-23 16820278 - J Chem Neuroanat. 2006 Aug;32(1):1-27 18590772 - Behav Brain Res. 2008 Dec 12;194(2):129-37 ES Graham (BFnpp2011188_CR23) 2009; 14 M Mackowiak (BFnpp2011188_CR32) 2009; 158 NC Coimbra (BFnpp2011188_CR11) 1993; 59 V de Paula Soares (BFnpp2011188_CR15) 2004; 64 SC Motta (BFnpp2011188_CR39) 2009; 106 JAS Crippa (BFnpp2011188_CR14) 2010; 32 DC Blanchard (BFnpp2011188_CR5) 1998; 22 KG Borelli (BFnpp2011188_CR7) 2004; 77 MH Pollack (BFnpp2011188_CR41) 2000; 14 AW Zuardi (BFnpp2011188_CR51) 1993; 7 JA Crippa (BFnpp2011188_CR13) 2004; 29 NC Coimbra (BFnpp2011188_CR12) 2006; 197 T Bisogno (BFnpp2011188_CR1) 2001; 134 NS Canteras (BFnpp2011188_CR9) 1997; 44 R Guimarães-Costa (BFnpp2011188_CR26) 2007; 165 BFnpp2011188_CR45 KG Borelli (BFnpp2011188_CR6) 2005; 1051 G Thiemann (BFnpp2011188_CR48) 2009; 200 AC Campos (BFnpp2011188_CR8) 2008; 199 K Mishima (BFnpp2011188_CR35) 2005; 36 GCD Eichenberger (BFnpp2011188_CR16) 2002; 42 B Lobão-Soares (BFnpp2011188_CR31) 2008; 194 D Mobbs (BFnpp2011188_CR36) 2007; 314 DP Finn (BFnpp2011188_CR17) 2003; 45 L Castellan-Baldan (BFnpp2011188_CR10) 2006; 32 P Fusar-Poli (BFnpp2011188_CR20) 2009; 66 SF Lisboa (BFnpp2011188_CR30) 2008; 593 BFnpp2011188_CR37 NM Simon (BFnpp2011188_CR47) 2009; 15 MR Zarrindast (BFnpp2011188_CR50) 2008; 19 DC Blanchard (BFnpp2011188_CR3) 2001; 25 EM Marco (BFnpp2011188_CR33) 2009; 48 SJ Ribeiro (BFnpp2011188_CR44) 2005; 30 E Mikics (BFnpp2011188_CR34) 2009; 20 A Thomas (BFnpp2011188_CR49) 2007; 150 LB Resstel (BFnpp2011188_CR42) 2008; 198 FG Graeff (BFnpp2011188_CR21) 1994; 27 RL Freitas (BFnpp2011188_CR18) 2009; 1305 G Griebel (BFnpp2011188_CR27) 1996; 20 AA Izzo (BFnpp2011188_CR28) 2009; 30 FA Moreira (BFnpp2011188_CR38) 2009; 23 FG Graeff (BFnpp2011188_CR22) 1986; 22 DC Blanchard (BFnpp2011188_CR4) 2003; 463 E Fride (BFnpp2011188_CR19) 2005; 4 DC Blanchard (BFnpp2011188_CR2) 1999; 23 AW Zuardi (BFnpp2011188_CR52) 2008; 30 JM Gorman (BFnpp2011188_CR24) 2000; 157 EB Russo (BFnpp2011188_CR46) 2005; 30 FS Guimarães (BFnpp2011188_CR25) 1990; 100 LB Resstel (BFnpp2011188_CR43) 2009; 156 ES Onaivi (BFnpp2011188_CR40) 2006; 1074 M Kellner (BFnpp2011188_CR29) 2009; 43 |
References_xml | – volume: 7 start-page: 82 year: 1993 ident: BFnpp2011188_CR51 publication-title: J Psychopharmacol doi: 10.1177/026988119300700112 contributor: fullname: AW Zuardi – volume: 77 start-page: 557 year: 2004 ident: BFnpp2011188_CR7 publication-title: Pharmacol Biochem Behav doi: 10.1016/j.pbb.2003.12.009 contributor: fullname: KG Borelli – volume: 4 start-page: 633 year: 2005 ident: BFnpp2011188_CR19 publication-title: Curr Drug Targets CNS Neurol Disord doi: 10.2174/156800705774933069 contributor: fullname: E Fride – volume: 198 start-page: 405 year: 2008 ident: BFnpp2011188_CR42 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1156-1 contributor: fullname: LB Resstel – volume: 200 start-page: 60 year: 2009 ident: BFnpp2011188_CR48 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.12.035 contributor: fullname: G Thiemann – volume: 100 start-page: 558 year: 1990 ident: BFnpp2011188_CR25 publication-title: Psychopharmacology (Berl) doi: 10.1007/BF02244012 contributor: fullname: FS Guimarães – ident: BFnpp2011188_CR37 doi: 10.1155/2009/625469 – ident: BFnpp2011188_CR45 doi: 10.1080/15622970801908047 – volume: 48 start-page: 20 year: 2009 ident: BFnpp2011188_CR33 publication-title: Rev Neurol contributor: fullname: EM Marco – volume: 197 start-page: 93 year: 2006 ident: BFnpp2011188_CR12 publication-title: Exp Neurol doi: 10.1016/j.expneurol.2005.08.022 contributor: fullname: NC Coimbra – volume: 27 start-page: 811 year: 1994 ident: BFnpp2011188_CR21 publication-title: Braz J Med Biol Res contributor: fullname: FG Graeff – volume: 23 start-page: 981 year: 1999 ident: BFnpp2011188_CR2 publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(99)00031-7 contributor: fullname: DC Blanchard – volume: 30 start-page: 184 year: 2005 ident: BFnpp2011188_CR44 publication-title: J Chem Neuroanat doi: 10.1016/j.jchemneu.2005.07.004 contributor: fullname: SJ Ribeiro – volume: 150 start-page: 613 year: 2007 ident: BFnpp2011188_CR49 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0707133 contributor: fullname: A Thomas – volume: 158 start-page: 1708 year: 2009 ident: BFnpp2011188_CR32 publication-title: Neurosci doi: 10.1016/j.neuroscience.2008.11.037 contributor: fullname: M Mackowiak – volume: 156 start-page: 181 year: 2009 ident: BFnpp2011188_CR43 publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2008.00046.x contributor: fullname: LB Resstel – volume: 593 start-page: 73 year: 2008 ident: BFnpp2011188_CR30 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2008.07.032 contributor: fullname: SF Lisboa – volume: 199 start-page: 223 year: 2008 ident: BFnpp2011188_CR8 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1168-x contributor: fullname: AC Campos – volume: 157 start-page: 493 year: 2000 ident: BFnpp2011188_CR24 publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.157.4.493 contributor: fullname: JM Gorman – volume: 44 start-page: 297 year: 1997 ident: BFnpp2011188_CR9 publication-title: Brain Res Bull doi: 10.1016/S0361-9230(97)00141-X contributor: fullname: NS Canteras – volume: 29 start-page: 417 year: 2004 ident: BFnpp2011188_CR13 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300340 contributor: fullname: JA Crippa – volume: 30 start-page: 1037 year: 2005 ident: BFnpp2011188_CR46 publication-title: Neurochem Res doi: 10.1007/s11064-005-6978-1 contributor: fullname: EB Russo – volume: 194 start-page: 129 year: 2008 ident: BFnpp2011188_CR31 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2008.06.006 contributor: fullname: B Lobão-Soares – volume: 22 start-page: 173 year: 1986 ident: BFnpp2011188_CR22 publication-title: Behav Brain Res doi: 10.1016/0166-4328(86)90038-0 contributor: fullname: FG Graeff – volume: 106 start-page: 4870 year: 2009 ident: BFnpp2011188_CR39 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0900939106 contributor: fullname: SC Motta – volume: 36 start-page: 1077 year: 2005 ident: BFnpp2011188_CR35 publication-title: Stroke doi: 10.1161/01.STR.0000163083.59201.34 contributor: fullname: K Mishima – volume: 32 start-page: 1 year: 2006 ident: BFnpp2011188_CR10 publication-title: J Chem Neuroanat doi: 10.1016/j.jchemneu.2006.05.002 contributor: fullname: L Castellan-Baldan – volume: 14 start-page: 944 year: 2009 ident: BFnpp2011188_CR23 publication-title: Front Biosci doi: 10.2741/3288 contributor: fullname: ES Graham – volume: 20 start-page: 265 year: 2009 ident: BFnpp2011188_CR34 publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e32832c70b1 contributor: fullname: E Mikics – volume: 1074 start-page: 514 year: 2006 ident: BFnpp2011188_CR40 publication-title: Proc Natl Acad Sci USA doi: 10.1196/annals.1369.052 contributor: fullname: ES Onaivi – volume: 14 start-page: S25 issue: Suppl 1 year: 2000 ident: BFnpp2011188_CR41 publication-title: J Psychopharmacol doi: 10.1177/02698811000142S104 contributor: fullname: MH Pollack – volume: 134 start-page: 845 year: 2001 ident: BFnpp2011188_CR1 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0704327 contributor: fullname: T Bisogno – volume: 1051 start-page: 100 year: 2005 ident: BFnpp2011188_CR6 publication-title: Brain Res doi: 10.1016/j.brainres.2005.05.068 contributor: fullname: KG Borelli – volume: 45 start-page: 594 year: 2003 ident: BFnpp2011188_CR17 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(03)00235-1 contributor: fullname: DP Finn – volume: 20 start-page: 185 year: 1996 ident: BFnpp2011188_CR27 publication-title: Prog Neuro-Psychopharmacol Biol Psychiatry doi: 10.1016/0278-5846(95)00305-3 contributor: fullname: G Griebel – volume: 66 start-page: 95 year: 2009 ident: BFnpp2011188_CR20 publication-title: Arch Gen Psychiatry doi: 10.1001/archgenpsychiatry.2008.519 contributor: fullname: P Fusar-Poli – volume: 30 start-page: 271 year: 2008 ident: BFnpp2011188_CR52 publication-title: Rev Bras Psiquiatr doi: 10.1590/S1516-44462008000300015 contributor: fullname: AW Zuardi – volume: 25 start-page: 205 year: 2001 ident: BFnpp2011188_CR3 publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(01)00009-4 contributor: fullname: DC Blanchard – volume: 32 start-page: 56 year: 2010 ident: BFnpp2011188_CR14 publication-title: Rev Bras Psiquiatr doi: 10.1590/S1516-44462010000500009 contributor: fullname: JAS Crippa – volume: 22 start-page: 597 year: 1998 ident: BFnpp2011188_CR5 publication-title: Neurosci Biobehav Rev doi: 10.1016/S0149-7634(97)00054-7 contributor: fullname: DC Blanchard – volume: 64 start-page: 181 year: 2004 ident: BFnpp2011188_CR15 publication-title: Brain Res Bull doi: 10.1016/j.brainresbull.2004.06.007 contributor: fullname: V de Paula Soares – volume: 15 start-page: 19 year: 2009 ident: BFnpp2011188_CR47 publication-title: CNS Neurosci Ther doi: 10.1111/j.1755-5949.2008.00076.x contributor: fullname: NM Simon – volume: 42 start-page: 48 year: 2002 ident: BFnpp2011188_CR16 publication-title: Neuropharmacology doi: 10.1016/S0028-3908(01)00155-1 contributor: fullname: GCD Eichenberger – volume: 59 start-page: 131 year: 1993 ident: BFnpp2011188_CR11 publication-title: Behav Brain Res doi: 10.1016/0166-4328(93)90159-N contributor: fullname: NC Coimbra – volume: 314 start-page: 1079 year: 2007 ident: BFnpp2011188_CR36 publication-title: Science doi: 10.1126/science.1144298 contributor: fullname: D Mobbs – volume: 23 start-page: 133 year: 2009 ident: BFnpp2011188_CR38 publication-title: Best Pract Res Clin Endocrinol Metab doi: 10.1016/j.beem.2008.09.003 contributor: fullname: FA Moreira – volume: 165 start-page: 25 year: 2007 ident: BFnpp2011188_CR26 publication-title: J Neurosci Meth doi: 10.1016/j.jneumeth.2007.05.023 contributor: fullname: R Guimarães-Costa – volume: 463 start-page: 97 year: 2003 ident: BFnpp2011188_CR4 publication-title: Eur J Pharmacol doi: 10.1016/S0014-2999(03)01276-7 contributor: fullname: DC Blanchard – volume: 30 start-page: 515 year: 2009 ident: BFnpp2011188_CR28 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2009.07.006 contributor: fullname: AA Izzo – volume: 19 start-page: 716 year: 2008 ident: BFnpp2011188_CR50 publication-title: Behav Pharmacol doi: 10.1097/FBP.0b013e3283123c83 contributor: fullname: MR Zarrindast – volume: 43 start-page: 642 year: 2009 ident: BFnpp2011188_CR29 publication-title: J Psychiatry Res doi: 10.1016/j.jpsychires.2008.09.001 contributor: fullname: M Kellner – volume: 1305 start-page: 118 year: 2009 ident: BFnpp2011188_CR18 publication-title: Brain Res doi: 10.1016/j.brainres.2009.09.096 contributor: fullname: RL Freitas |
SSID | ssj0015768 |
Score | 2.3850436 |
Snippet | Several pharmacological targets have been proposed as modulators of panic-like reactions. However, interest should be given to other potential therapeutic... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 412 |
SubjectTerms | Adult and adolescent clinical studies Animals Anti-Anxiety Agents - pharmacology Anti-Anxiety Agents - therapeutic use Anxiety disorders. Neuroses Biological and medical sciences Cannabidiol - pharmacology Cannabidiol - therapeutic use Disease Models, Animal Epicrates cenchria Fear - drug effects Humans Instinct Male Medical sciences Mice Original Panic attacks Panic disorder Panic Disorder - drug therapy Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Snakes |
Title | Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21918503 https://www.proquest.com/docview/910398627 https://search.proquest.com/docview/1008840700 https://search.proquest.com/docview/911936782 https://pubmed.ncbi.nlm.nih.gov/PMC3242302 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLboHhASQqPjEgbVQYI9LWtunePHUjptQkOVNqS9Rb6FRVvdqEkr9SfuX3HsJB1F8MJb0zhu5H72-Y7POZ8J-WS1YOOIWT08u3WTB8znQqPXir6IkCpRylW5nl_R7zfp16mVyRl1tTAuaV-K4sTcz09McetyK8u5HHZ5YsPZ5cSRgCAa9kgPuWHnorehA0ugHXVksY8O2E2b7R7E6dCUZSPaGaapUwFmaK2647Jak_S85BWOTt4ca_E33vln-uRv9uhsn7xoiSSMmxd-SZ5o0ycHY4NO9HwDR-BSO92eeZ88vWwj6H1yNGu0qjfHcP1YelUduye2KtabA_IwNnXhj13WxlpDo3JcwSKHCTeGi0Jh77AwcIFXtQbkkkvfHgQitYJWdXFZwXS9uMMvxAa4gWm9XWvBHsJ2b7ubcVNIGNe1rfaHL2hVle2WwwxRBusKkKICLl4Krgy_wzcpC2n1LSrAkZG3OIEArxE-FdjyRSvI4NCGHS-5Kn7OX5EfZ9Prybnfnvvgy4TGtS2REyMahJozoQIZMRXlCVpYTlMtTxOW5jRPc8FOE4FkJxERR0eS80Ak3Kqrqfg12TMLo98SSETo9HVySUf4ORRU5zTkUSiQaQa59Mjn7q_PykbeI3Nh-TjNEC2ZRUuGaPHIYAcX28bIGJOQpswjhx1QsnYVqDJm4-zoMlKPfNzexelrYzLc6MWqspLRKfrYNAg8Av9og_aIxUgqIo-8aZD3-PMthD1CdzC5bWDVw3fv4KRyKuLtJHr3308ekmc4PFGzH_We7NXLlf5AepVaDdA3ufg2cPPyF3I-Po8 |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbYkAAJcem4hME4SLCnZc2tc_xYSqdOrFOlFWlvkS8Ji7a6UZNW6k_kX3HsJB1F8LK3JHac1vrs8x37-DuEfDZasGHAjB6eWbrJPOZykaLXir6IkCpSyp5yHV3Si6v429DI5PTaszA2aF-K_Fjfzo51fm1jK4uZ7LZxYt3JeGBJgBd0d8hDHK-e1zrpzeaBodCWPLLQRRfsqol398K4q4uilu3049jqADO0V23CrMYoPS14if2T1Ykt_sU8_w6g_MMinT6_5395QZ41FBT6dfFL8iDVHbLX1-h-z9ZwCDYo1K62d8ijcbP33iGHk1rlen0E07tDW-WRfWOjf73eI7_6usrdvo33WKVQ6yOXMM9gwLXmIlfYOsw1nOFdlQKy0IVrUojIVEGj17goYbia3-ADsQauYVhtZmkw6dtuTXMTrnMJ_aoyOgHwFe2xMs1ymCA-YVUCklvAaU_BpeY3-EuKXBpljBKwR-U1Dj3AewReCebgo5FysDjFhhdc5T9nr8iP0-F0MHKbjBGujGhYmcN1okc9P-VMKE8GTAVZhLaZ0ziVJxGLM5rFmWAnkUCaFImAowvKuScibnTZVPia7Oq5Tt8SiIRvlXkySXt47QuaZtTngS-Qo3qZdMiXFjJJUQuDJHZDP4wTRFliUJYgyhxysIWnTWXkmpFPY-aQ_RZgSTN_lAkzO_TobFKHfNqU4sA3uzlcp_NlacSmY_TOqec5BP5TBy0ZC5GOBA55UyP27vMN9B1Ct7C8qWB0x7dLEMJWf7yB7Lt7v_mRPB5Nx-fJ-dnF933yBLsqqFe13pPdarFMP5CdUi0P7Kj-DQ03Uw4 |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3bbtNAEB3RIlVIiEvKxRTKIEGf6sa3du3HkCZqBa0itUh9s_ZiU6vNxoqdSvlE_orZteMSBC_wFsfrdbI6u3NmZ_YMwEejBRsGidHDM1s3uZe4XGTktZIvIqSKlLKnXE8u2PlVfDwyMjldqS-btC9FcaBvpwe6uLa5leVU9ld5Yv3J2dCSAC_olyrvb8BDmrNesHLU2wCCodGWQCahS27YVZvz7oVxX5dlI93px7HVAk7IZq2KZrWG6XHJKxqjvClu8Sf2-XsS5S9Wafz0P_7PM3jSUlEcNE2ew4NM92B7oMkNny5xD21yqN1178HWWRuD78HepFG7Xu7j5f3hrWrfPtHpYC-34cdA14U7sHkfdxk2OskVznIccq25KBT1jjONp3RVZ0hsdO6aUiIyU9jqNs4rHN3NbugLsUSucVR3qzWaMm63prsJ14XEQV0bvQD8THZZmW45TgineFchkVyk5U_hheY39EvKQhqFjAppVOU1TUGkawJgheYApJF0sHiljudcFd-nL-DbeHQ5PHHbyhGujFhYm0N24pB5fsYToTwZJCrII7LRnMWZPIqSOGd5nIvkKBJElyIRcHJFOfdExI0-mwpfwqae6ew1YCR8q9CTS3ZIn33Bspz5PPAFcVUvlw58WsEmLRuBkNQG9sM4JaSlBmkpIc2B3TVMdY2Jc0Y-ixMHdlYgS9t1pEoTE6knp5M58KG7SwuAiepwnc0WlRGdjslLZ57nAP6lDVm0JCRaEjjwqkHt_etb-DvA1vDcNTD64-t3CMZWh7yF7Zt_fvI9bE2Ox-nX0_MvO_CIRipoNrfewmY9X2TvYKNSi107sX8CgMJVjg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anti-Aversive+Effects+of+Cannabidiol+on+Innate+Fear-Induced+Behaviors+Evoked+by+an+Ethological+Model+of+Panic+Attacks+Based+on+a+Prey+vs+the+Wild+Snake+Epicrates+cenchria+crassus+Confrontation+Paradigm&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Uribe-Marino%2C+Andres&rft.au=Francisco%2C+Audrey&rft.au=Castiblanco-Urbina%2C+Maria+Angelica&rft.au=Twardowschy%2C+Andre&rft.date=2012-01-01&rft.issn=0893-133X&rft.volume=37&rft.issue=2&rft.spage=412&rft.epage=421&rft_id=info:doi/10.1038%2Fnpp.2011.188&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |